McAdam LLC’s Medtronic MDT Stock Holding History

McAdam LLC’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-50	Closed	-$4K	–	739
2018 Q1	$4K	Buy	+50	New	+$4.12K	﹤0.01%	436

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

McAdam LLC's MDT Position: Q2 2018 in Review

McAdam LLC sold out of Medtronic (MDT) in Q2 2018, closing a stake of 50 shares — an estimated $4K sold.

McAdam LLC first reported a position in MDT in Q1 2018 and held it in 1 quarter. The position peaked at $4K in Q1 2018. 1,409 funds tracked by Wall St. Rank hold MDT as of Q2 2018.

McAdam LLC reported no remaining Medtronic position as of Q2 2018 after selling out during the quarter.
McAdam LLC sold 50 Medtronic shares in Q2 2018, an estimated $4K.
McAdam LLC first reported a position in Medtronic in Q1 2018 and held it in 1 quarter.
McAdam LLC's Medtronic position peaked at $4K in Q1 2018.
1,409 funds tracked by Wall St. Rank held Medtronic as of Q2 2018.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.